Title : Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors - Rockwood_2017_Alzheimers.Dement_13_1098 |
Author(s) : Rockwood K , Howlett SE , Hoffman D , Schindler R , Mitnitski A |
Ref : Alzheimers Dement , 13 :1098 , 2017 |
Abstract : |
PubMedSearch : Rockwood_2017_Alzheimers.Dement_13_1098 |
PubMedID: 28341540 |
Title : Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors - Rockwood_2017_Alzheimers.Dement_13_1098 |
Author(s) : Rockwood K , Howlett SE , Hoffman D , Schindler R , Mitnitski A |
Ref : Alzheimers Dement , 13 :1098 , 2017 |
Abstract : |
PubMedSearch : Rockwood_2017_Alzheimers.Dement_13_1098 |
PubMedID: 28341540 |
Title : Butyrylcholinesterase is associated with beta-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease - Darvesh_2012_J.Neuropathol.Exp.Neurol_71_2 |
Author(s) : Darvesh S , Cash MK , Reid GA , Martin E , Mitnitski A , Geula C |
Ref : J Neuropathol Experimental Neurology , 71 :2 , 2012 |
Abstract : |
PubMedSearch : Darvesh_2012_J.Neuropathol.Exp.Neurol_71_2 |
PubMedID: 22157615 |
Title : Butyrylcholinesterase is associated with beta-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease - Darvesh_2012_J.Neuropathol.Exp.Neurol_71_2 |
Author(s) : Darvesh S , Cash MK , Reid GA , Martin E , Mitnitski A , Geula C |
Ref : J Neuropathol Experimental Neurology , 71 :2 , 2012 |
Abstract : |
PubMedSearch : Darvesh_2012_J.Neuropathol.Exp.Neurol_71_2 |
PubMedID: 22157615 |
Title : Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months - Rockwood_2008_Int.J.Geriatr.Psychiatry_23_207 |
Author(s) : Rockwood K , Dai D , Mitnitski A |
Ref : Int J Geriatr Psychiatry , 23 :207 , 2008 |
Abstract : |
PubMedSearch : Rockwood_2008_Int.J.Geriatr.Psychiatry_23_207 |
PubMedID: 17621382 |
Title : Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months - Rockwood_2008_Int.J.Geriatr.Psychiatry_23_207 |
Author(s) : Rockwood K , Dai D , Mitnitski A |
Ref : Int J Geriatr Psychiatry , 23 :207 , 2008 |
Abstract : |
PubMedSearch : Rockwood_2008_Int.J.Geriatr.Psychiatry_23_207 |
PubMedID: 17621382 |